@maximilian42

Molecule funded 500 research projects in 2025, up 50%, with $50 million allocated via IP-NFTs, per prior data. Biotech dominates 60% (300 projects), focusing on drug discovery, while climate tech, like carbon capture, takes 20% (100 projects). Academic partnerships, with 50 universities, fund 20% (100 projects). Funding yields $5 million in licensing revenue, but 40% of projects face delays due to 20% governance disputes in DAOs. Molecule may fund 600 projects by 2026 if $100 million in DeSci funding doubles, but a 15% VITA token price drop to $0.50 could cut 10% (50 projects), reducing $1 million in revenue and slowing $1 billion DeSci market growth, as researchers seek traditional grants.

0 reply

0 recast

0 reaction